ID

29899

Beschrijving

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301); ODM derived from: https://clinicaltrials.gov/show/NCT00446524

Link

https://clinicaltrials.gov/show/NCT00446524

Trefwoorden

Versies (1)
  1. 26-04-18 26-04-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

26 april 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Hypertension NCT00446524

Engels

Eligibility Hypertension NCT00446524

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who successfully complete the core study (study cvaa489a1301.
Beschrijving

Clinical Trial Successful Completed

Datatype

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1272703
UMLS CUI [1,3]
C0205197
patients whose blood pressure at visit 7 of the study cvaa489a1301 had to be well controlled defined as msdbp < 90 mmhg and mssbp < 140 mmhg. at the investigator's or sub-investigator's discretion, those patients who were not well controlled (msdbp ≥
Beschrijving

Blood Pressure Well controlled | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005823
UMLS CUI [1,2]
C3853142
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
90 mmhg or mssbp ≥ 140 mmhg), and whose msdbp was < 100 mmhg and mssbp was < 160 mmhg might participate in the extension if this was considered an acceptable level of blood pressure control for the patient.
Beschrijving

Blood Pressure Poorly controlled | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005823
UMLS CUI [1,2]
C3853134
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
male or female outpatients.
Beschrijving

Outpatients

Datatype

boolean

Alias
UMLS CUI [1]
C0029921
patients who have written informed consent to participate in this study.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of major protocol violation in study cvaa489a1301.
Beschrijving

Protocol Violation Major

Datatype

boolean

Alias
UMLS CUI [1,1]
C1709750
UMLS CUI [1,2]
C0205164
patients who experienced any adverse events considered serious and drug related in study cvaa489a1301.
Beschrijving

Serious Adverse Event | Adverse reaction to drug

Datatype

boolean

Alias
UMLS CUI [1]
C1519255
UMLS CUI [2]
C0041755
patients who experienced any adverse events considered serious and drug related in study cvaa489a1301.
Beschrijving

Serious Adverse Event | Adverse reaction to drug

Datatype

boolean

Alias
UMLS CUI [1]
C1519255
UMLS CUI [2]
C0041755
patients who are considered unlikely to comply with the requirements specified in the protocol by the investigator or sub-investigator.
Beschrijving

Protocol Compliance Unlikely

Datatype

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C0750558
patients who have gout or gouty arthritis.
Beschrijving

Gout | Arthritis, Gouty

Datatype

boolean

Alias
UMLS CUI [1]
C0018099
UMLS CUI [2]
C0003868
patients hypersensitive to diuretics (except for potassium sparing diuretics).
Beschrijving

Diuretic allergy | Exception Potassium Sparing Diuretics

Datatype

boolean

Alias
UMLS CUI [1]
C0571893
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0304490
other protocol-defined inclusion/exclusion criteria may apply
Beschrijving

Eligibility Criteria Study Protocol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Terug naar het begin van de pagina

Similar models

Eligibility Hypertension NCT00446524

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Clinical Trial Successful Completed
Item
patients who successfully complete the core study (study cvaa489a1301.
boolean
C0008976 (UMLS CUI [1,1])
C1272703 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Blood Pressure Well controlled | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
patients whose blood pressure at visit 7 of the study cvaa489a1301 had to be well controlled defined as msdbp < 90 mmhg and mssbp < 140 mmhg. at the investigator's or sub-investigator's discretion, those patients who were not well controlled (msdbp ≥
boolean
C0005823 (UMLS CUI [1,1])
C3853142 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Blood Pressure Poorly controlled | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
90 mmhg or mssbp ≥ 140 mmhg), and whose msdbp was < 100 mmhg and mssbp was < 160 mmhg might participate in the extension if this was considered an acceptable level of blood pressure control for the patient.
boolean
C0005823 (UMLS CUI [1,1])
C3853134 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Outpatients
Item
male or female outpatients.
boolean
C0029921 (UMLS CUI [1])
Informed Consent
Item
patients who have written informed consent to participate in this study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Protocol Violation Major
Item
presence of major protocol violation in study cvaa489a1301.
boolean
C1709750 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
Serious Adverse Event | Adverse reaction to drug
Item
patients who experienced any adverse events considered serious and drug related in study cvaa489a1301.
boolean
C1519255 (UMLS CUI [1])
C0041755 (UMLS CUI [2])
Serious Adverse Event | Adverse reaction to drug
Item
patients who experienced any adverse events considered serious and drug related in study cvaa489a1301.
boolean
C1519255 (UMLS CUI [1])
C0041755 (UMLS CUI [2])
Protocol Compliance Unlikely
Item
patients who are considered unlikely to comply with the requirements specified in the protocol by the investigator or sub-investigator.
boolean
C0525058 (UMLS CUI [1,1])
C0750558 (UMLS CUI [1,2])
Gout | Arthritis, Gouty
Item
patients who have gout or gouty arthritis.
boolean
C0018099 (UMLS CUI [1])
C0003868 (UMLS CUI [2])
Diuretic allergy | Exception Potassium Sparing Diuretics
Item
patients hypersensitive to diuretics (except for potassium sparing diuretics).
boolean
C0571893 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0304490 (UMLS CUI [2,2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial